Topic prioritisation
Showing 1 to 7 of 7
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165] | None selected | Not selected | |
| Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043] | None selected | Not selected | |
| Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043] | None selected | Not selected | |
| Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868] | None selected | Not selected | |
| Olorofim for treating invasive fungal infections in people 16 years and over [TSID11983] | None selected | Not selected | |
| Darunavir plus cobicistat fixed dose combination for paediatric human immunodeficiency virus 1 infection [TSID10722] | None selected | Not selected | |
| Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723] | None selected | Not selected |